The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system

Otte, Andrew; Báez-Santos, Yahira M.; Mun, Ellina A.; Soh, Bong-Kwan; Lee, Young-nam; Park, Kinam

doi:10.1016/j.ijpharm.2017.08.098

Title: The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system

Full Record
Other Related Research

Authors:: Otte, Andrew; Báez-Santos, Yahira M.; Mun, Ellina A.; Soh, Bong-Kwan; Lee, Young-nam; Park, Kinam

Publication Date:: 2017-10-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1549792

Grant/Contract Number:: AC02-06CH11357

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: International Journal of Pharmaceutics

Additional Journal Information:: Journal Name: International Journal of Pharmaceutics Journal Volume: 532 Journal Issue: 1; Journal ID: ISSN 0378-5173

Publisher:: Elsevier

Country of Publication:: Netherlands

Language:: English

Citation Formats


                    Otte, Andrew, Báez-Santos, Yahira M., Mun, Ellina A., Soh, Bong-Kwan, Lee, Young-nam, and Park, Kinam. The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system.  Netherlands: N. p., 2017. 
Web.  doi:10.1016/j.ijpharm.2017.08.098.

Copy to clipboard


                    Otte, Andrew, Báez-Santos, Yahira M., Mun, Ellina A., Soh, Bong-Kwan, Lee, Young-nam, & Park, Kinam. The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system.  Netherlands.  https://doi.org/10.1016/j.ijpharm.2017.08.098

Copy to clipboard


                    Otte, Andrew, Báez-Santos, Yahira M., Mun, Ellina A., Soh, Bong-Kwan, Lee, Young-nam, and Park, Kinam. Sun .  
"The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system".  Netherlands.  https://doi.org/10.1016/j.ijpharm.2017.08.098.

Copy to clipboard


                    
@article{osti_1549792,

  title        = {The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system},

  author       = {Otte, Andrew and Báez-Santos, Yahira M. and Mun, Ellina A. and Soh, Bong-Kwan and Lee, Young-nam and Park, Kinam},

  abstractNote = {},

  doi          = {10.1016/j.ijpharm.2017.08.098},

  journal      = {International Journal of Pharmaceutics},

  number       = 1,

  volume       = 532,

  place        = {Netherlands},

  year         = {2017},

  month        = {10}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.ijpharm.2017.08.098

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 4 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system

Journal Article Otte, Andrew ; Báez-Santos, Yahira M. ; Mun, Ellina A. ; ... - International Journal of Pharmaceutics
https://doi.org/10.1016/j.ijpharm.2017.08.098
Local Delivery System of Immune Modulating Drug for Unresectable Adenocarcinoma: In Vitro Experimental Study and In Vivo Animal Study

Journal Article Lee, Don Haeng ; Kang, Sung-Gwon ; Jeong, Seok ; ... - Cardiovascular and Interventional Radiology

The purpose of the study was to evaluate the efficacy and safety of a developed drug delivery system containing OK-432 through in vitro and animal study. An OK-432-impregnated polycarbonate/polyurethane stent membrane was used to develop a drug delivery system (DDS) enabling the locoregional release of OK-432. Polyethyleneglycol was used as a detergent and porosity generator. The stability of OK-432 in solvent, releasing kinetics of drug, and cytotoxicity of the DDS were evaluated. OK-432-impregnated DDS was implanted in mice in which a human adenocarcinoma cell line was injected and grown in their back. Flow cytometry and enzyme-linked immunosorbent assay were usedmore »« less
https://doi.org/10.1007/S00270-005-0194-X
Fast understanding of phases and phase separation in liquid crystal drug delivery systems using deuterium solid-state NMR

Journal Article Abraham, A ; Chan, E. ; Park, H. - Solid State Nuclear Magnetic Resonance
https://doi.org/10.1016/j.ssnmr.2020.101642
Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetate

Journal Article Báez-Santos, Yahira M. ; Otte, Andrew ; Mun, Ellina A. ; ... - International Journal of Pharmaceutics
Cited by 7
https://doi.org/10.1016/j.ijpharm.2016.06.138
(Pentamethylcyclopentadienato)rhodium complexes for delivery of the curcumin anticancer drug [Rhodium pentamethylcyclopentadienato complexes for delivery of the curcumin anti-cancer drug]

Journal Article Markham, Jack ; Liang, Jun ; Levina, Aviva ; ... - European Journal of Inorganic Chemistry

[RhIII(*Cp)Cl(X,Y)]ⁿ⁺ complexes {X, Y = Cl, PTA, n = 0 (2); X, Y = en, n = 1 (3, Cl– salt; 4, PF₆– salt); X, Y = acac, n = 0 (5); X, Y = cur, n = 0 (6), where *Cp = pentamethylcyclopentadienato, curH = curcumin; PTA = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane; en = 1,2-ethanediamine; acac = acetylacetonato = 2,4-pentanedionato(1–)} were synthesized from [Rh(*Cp)(µ-Cl)Cl]₂ (1). While 2–5 were inactive against human epithelial A549 lung-cancer cells in assays of cytotoxicity, and antimetastatic and proapoptotic behaviors, 6 had a cytotoxic activity similar to that of curH over 72 h, but at 24 h inmore »« less
Cited by 3
https://doi.org/10.1002/ejic.201601331

Full Text Available

Similar Records